e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Sarcoidosis and profiles of other diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late idiopathic pneumonia syndrome after hematopoietic bone marrow transplantation: prognosis remains poor despite the use of etanercept
C. Tcherakian, E. Rivaud, E. Longchamp, N. Dhedin, D. Uzunof, J. P. Vernant, L. J. Couderc (Suresnes, Paris, France)
Source:
Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Session:
Sarcoidosis and profiles of other diffuse parenchymal lung disease
Session type:
E-Communication Session
Number:
3132
Disease area:
Interstitial lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Tcherakian, E. Rivaud, E. Longchamp, N. Dhedin, D. Uzunof, J. P. Vernant, L. J. Couderc (Suresnes, Paris, France). Late idiopathic pneumonia syndrome after hematopoietic bone marrow transplantation: prognosis remains poor despite the use of etanercept. Eur Respir J 2009; 34: Suppl. 53, 3132
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
Source: Eur Respir J 2005; 25: 490-493
Year: 2005
Pulmonary dysfunction after bone marrow transplantation (BMT) for thalassemia major: long-term results
Source: Eur Respir J 2004; 24: Suppl. 48, 157s
Year: 2004
Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018
Bone marrow transplantation in thalassaemia major and severe aplastic anaemia: pulmonary complications
Source: Eur Respir J 2001; 18: Suppl. 33, 120s
Year: 2001
Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
Late Breaking Abstract - High cumulative dose of allogeneic mesenchymal stem cells in patients with progressive idiopathic pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
Pulmonary involvement in haematological disorders and bone marrow transplant recipients
Source: Eur Respir Monogr 2019; 86: 333-358
Year: 2019
Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Telespirometry for home monitoring of pulmonary function in patients after allogeneic bone marrow transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 242s
Year: 2003
Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Pulmonary hypertension after bone marrow transplantation in children
Source: Eur Respir J, 54 (5) 1900612; 10.1183/13993003.00612-2019
Year: 2019
Late pulmonary complications after haematopoietic stem cell transplantation (HSCT) in children: incidence and risk factors
Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects
Year: 2008
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant
Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017
Year: 2018
The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2008 - Pathophysiology of acute lung injury
Year: 2008
Predictive factors for respiratory failure after autologous bone marrow transplantation: the impact of alcohol abuse
Source: Annual Congress 2008 - Acute lung injury and weaning
Year: 2008
Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept